SEC Filing (S-1) - Registration Statement - General Form
(WorldNews Netherlands)

Table of Contents As filed with the Securities and Exchange Commission on September 25, 2020. Registration No. 333-[__] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CNS Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 2834 82-2318545 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 2100 West Loop South, Suite 900 Houston, TX 77027 (800) 946-9185 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant`s Principal Executive...